66378 Federal Register / Vol. 75, No. 208 / Thursday, October 28, 2010 / Notices 

DATES: Comments should be received on 

or before November 29, 2010 to be 

assured of consideration. 

ADRESSES: Comments maybe submitted 

electronically on http:// 

www.regulations.gov or by mail to 

Office of Information and Regulatory 

Affairs, 725 17th Street, NW., 

Washington, DC 20038 Attn: OMB 

3048–0016. 

SUPPLEMENTARY INFORMATION: 

Titles and Form Number: EIB 92–36 

Application for Issuing Bank Credit 

Limit under Letter of Credit Insurance 

Policy. 

OMB Number: 3048–0016. 

Type of Review: Regular. 

Need and Use: The Application for 

Issuing Bank Credit Limit under Letter 

of Credit Insurance Policy will be used 

to determine the eligibility of the 

issuing bank and the transaction for 

Export Import Bank assistance under its 

insurance program. 

Sharon A. Whitt, 

Agency Clearance Officer. 

[FR Doc. 2010–27253 Filed 10–27–10; 8:45 am] 

BILLING CODE 6690–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The application also will be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than November 22, 

2010. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President), 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. Vogel Bancshares, Inc., Orange 

City, Iowa; to acquire up to 100 percent 

of the voting shares of Farmers Savings 

Bank, Remsen, Iowa. 

B. Federal Reserve Bank of San 

Francisco (Kenneth Binning, Vice 

President, Applications and 

Enforcement), 101 Market Street, San 

Francisco, California 94105–1579: 

1. Carpenter Fund Manager GP, LLC, 

Carpenter Fund Management Company, 

LLC, Carpenter Community Bancfund, 

L.P., Carpenter Community Bancfund— 

A, L.P., Carpenter Community 

Bancfund—CA, L.P., CGB Holdings, 

Inc., CCFW, Inc., and SCJ, Inc.; all of 

Irvine, California; to acquire 100 percent 

of the voting shares of Professional 

Business Bank, Pasadena, California, 

which will merge with California 

General Bank, Pasadena, California. 

In connection with this Application, 

CGB Holdings, Inc., Irvine, California, 

has applied to acquire 100 percent of 

the voting shares of CGB Asset 

Management, Inc., Irvine, California, 

and thereby engage in extending credit 

and servicing loans, pursuant to section 

225.28(b)(1) of Regulation Y. 

Board of Governors of the Federal Reserve 

System, October 25, 2010. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 2010–27280 Filed 10–27–10; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Public Meeting of the Presidential 

Commission for the Study of 

Bioethical Issues 

AGENCY: Department of Health and 

Human Services, Office of the Assistant 

Secretary for Health, The Presidential 

Commission for the Study of Bioethical 

Issues. 

ACTION: Notice of Meeting. 

SUMMARY: The Presidential Commission 

for the Study of Bioethical Issues 

(PCSBI) will conduct its third meeting 

in November. At this meeting, the 

Commission will continue discussing 

the emerging science of synthetic 

biology, including its potential benefits 

and risks, and appropriate ethical 

boundaries and principles. The 

Commission will develop and finalize 

recommendations concerning any 

actions that the Federal Government 

should take to ensure that America 

reaps the benefits of this developing 

field of science while identifying 

appropriate ethical boundaries and 

minimizing risks. It will also identify 

suggestions for future study, if any. 

DATES: The meeting will take place 

Tuesday, November 16, 2010, from 

10:30 a.m. to approximately 4:15 p.m., 

and Wednesday, November 17, 2010, 

from 9 a.m. to approximately 11:30 a.m. 

ADDRESSES: Emory Conference Center 

Hotel, 1615 Clifton Road, Atlanta, GA 

30329. Phone 404–712–6000. 

FOR FURTHER INFORMATION CONTACT: Judy 

Crawford, The Presidential Commission 

for the Study of Bioethical Issues, 1425 

New York Avenue, NW., Suite C–100, 

Washington, DC 20005. Telephone: 

202/233–3960. E-mail: 

judy.crawford@bioethics.gov. 

Additional information may be obtained 

by viewing the Web site: http:// 

www.bioethics.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to the Federal Advisory Committee Act, 

Public Law 92–463, as amended 5 

U.S.C. App., notice is hereby given of 

the third meeting of the PCSBI. The 

meeting will be held from 10:30 a.m. to 

approximately 4:15 p.m. on Tuesday, 

November 16, 2010, and from 9 a.m. to 

approximately 11:30 a.m. on 

Wednesday, November 17, 2010, at the 

Emory Conference Center Hotel, 

Atlanta, GA. The meeting will be open 

to the public with attendance limited to 

space available. The meeting will also 

be Web cast at http://www.bioethics.gov. 

Under authority of Executive Order 

13521, dated November 24, 2009, the 

President established the PCSBI to serve 

as a public forum and advise him on 

bioethical issues generated by novel and 

emerging research in biomedicine and 

related areas of science and technology. 

The Commission is charged to identify 

and promote policies and practices that 

assure ethically responsible conduct of 

scientific research, healthcare delivery, 

and technological innovation. In 

undertaking these duties, the 

Commission will examine specific 

bioethical, legal, and social issues 

related to potential scientific and 

technological advances; examine 

diverse perspectives and explore 

possibilities for useful international 

collaboration on these issues, and 

recommend legal, regulatory, or policy 

actions as appropriate. The main agenda 

items for this third meeting involve 

further discussion of the opportunities 

and benefits to the public of the 


emcdonald on DSK2BSOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 208 / Thursday, October 28, 2010 / Notices 66379 

emerging science of synthetic biology, 

the challenges and risks, and the ethical 

boundaries that may be important to 

formulation of public policy with regard 

to this advancing science. The 

Commission also will develop and 

finalize recommendations concerning 

any actions that the Federal Government 

should take to ensure that America 

reaps the benefits of this developing 

field of science while identifying 

appropriate ethical boundaries and 

minimizing risks. It will also identify 

suggestions for future study, if any. The 

draft meeting agenda and other 

information about PCSBI, including 

information about access to the Web 

cast, will be available at http:// 

www.bioethics.gov. 

The Commission welcomes input 

from anyone wishing to provide public 

comment on any issue before it. 

Individuals who would like to provide 

public comment at the meeting should 

notify Judy Crawford by telephone at 

202–233–3960, or e-mail at 

judy.crawford@bioethics.gov. Anyone 

planning to attend the meeting who 

needs special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

also notify Judy Crawford in advance of 

the meeting. The Commission will make 

every effort to accommodate persons 

who need special assistance. 

Written comments will also be 

accepted. Please address written 

comments by e-mail to 

info@bioethics.gov, or by mail to the 

following address: Public Commentary, 

The Presidential Commission for the 

Study of Bioethical Issues, 1425 New 

York Ave. NW., Suite C–100, 

Washington, DC 20005. Comments will 

be publicly available, including any 

personally identifiable or confidential 

business information that they contain. 

Trade secrets should not be submitted. 

Dated: October 22, 2010. 

Valerie H. Bonham, 

Executive Director, The Presidential 

Commission for the Study of Bioethical Issues. 

[FR Doc. 2010–27233 Filed 10–27–10; 8:45 am] 

BILLING CODE 4154–06–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: 

Comment Request 

In compliance with the requirement 

for opportunity for public comment on 

proposed data collection projects 

(section 3506(c)(2)(A) of Title 44, United 

States Code, as amended by the 

Paperwork Reduction Act of 1995, Pub. 

L. 104–13), the Health Resources and 

Services Administration (HRSA) 

publishes periodic summaries of 

proposed projects being developed for 

submission to the Office of Management 

and Budget (OMB) under the Paperwork 

Reduction Act of 1995. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and draft instruments, e-mail 

paperwork@hrsa.gov or call the HRSA 

Reports Clearance Officer at (301) 443– 

1129. 

Comments are invited on: (a) The 

proposed collection of information for 

the proper performance of the functions 

of the agency; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. 

Proposed Project: Ryan White HIV/ 

AIDS Treatment Extension Act of 2009: 

Program Allocation and Expenditure 

Forms (OMB No. 0915–0318)— 

Extension 

The Ryan White HIV/AIDS Program 

Allocation and Expenditure Reports will 

enable the Health Resources and 

Services Administration’s (HRSA) HIV/ 

AIDS Bureau to track spending 

requirements for each program as 

outlined in the 2009 legislation. 

Grantees funded under Parts A, B, C, 

and D of the Ryan White HIV/AIDS 

Program (codified under Title XXVI of 

the Public Health Service Act) would be 

required to report financial data to 

HRSA at the beginning and end of the 

grant cycle. 

All Parts of the Ryan White HIV/AIDS 

Program specify HRSA’s responsibilities 

in the administration of grant funds. 

Accurate allocation and expenditure 

records of the grantees receiving Ryan 

White HIV/AIDS Program funding are 

critical to the implementation of the 

legislation and thus are necessary for 

HRSA to fulfill its responsibilities. 

The forms would continue to require 

grantees to report on how funds are 

allocated and spent on core and noncore services, and on various program 

components, such as administration, 

planning and evaluation, and quality 

management. The two forms are 

identical in the types of information that 

are collected. However, the first report 

would track the allocation of the award 

at the beginning of the grant cycle and 

the second report would track actual 

expenditures (including carryover 

dollars) at the end of the grant cycle. 

The primary purposes of these forms 

are to (1) provide information on the 

number of grant dollars spent on various 

services and program components, and 

(2) oversee compliance with the intent 

of Congressional appropriations in a 

timely manner. In addition to meeting 

the goal of accountability to the 

Congress, clients, advocacy groups, and 

the general public, information 

collected on these reports is critical for 

HRSA, State, and local grantees, and 

individual providers to evaluate the 

effectiveness of these programs. The 

annual estimate of burden is as follows: 

Program under which grantee is funded 

Number of 

grantee 

respondents 

Responses 

per grantee 

Total 

responses 

Hours to 

complete each 

form 

Total burden 

hours 

Part A ................................................................................... 56 2 112 8 896 

Part B ................................................................................... 59 2 118 12 1416 

Part A MAI ........................................................................... 56 2 112 4 448 

Part B MAI ........................................................................... 59 2 118 4 472 

Part C ................................................................................... 361 2 722 7 5054 

Part D ................................................................................... 90 2 180 7 1260 

Total .............................................................................. 681 ........................ 1,362 ........................ 9,546 


emcdonald on DSK2BSOYB1PROD with NOTICES